LRRK2 and Parkinson disease: Consistent with the above findings showing no change or even decreased pS935-LRRK2 in PD and DLB, we found no significant difference in pS935-LRRK2 in the brains from DLB or AD cases compared to control brains, and as such does not appear to be elevated in neurodegenerative disease brain tissue.